GMED (Globus Medical, Inc.) Stock Financials & Earnings | Market Cap Arena

GMED (Globus Medical, Inc.) Stock Financials & Earnings | Market Cap Arena

GMEDGlobus Medical, Inc.

Mkt Cap$12B

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Revenue (TTM)$2.9B

Net Income (TTM)$538M

EPS (TTM)$3.92

Free Cash Flow (TTM)$579M

Gross Margin67.4%

Op. Margin16.3%

Net Margin18.3%

FCF Margin19.7%

P/S Ratio (TTM)4.0x

P/E Ratio (TTM)22.0x

YoY Rev Growth+16.7%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$277M	$206M	$56M
Q2 23	$292M	$215M	$66M
Q3 23	$384M	$248M	$404K
Q4 23	$617M	$351M	$10M
Q1 24	$607M	$365M	$8M
Q2 24	$630M	$370M	$50M
Q3 24	$626M	$355M	$48M
Q4 24	$657M	$394M	$60M
Q1 25	$598M	$403M	$97M
Q2 25	$745M	$497M	$76M
Q3 25	$769M	$487M	$135M
Q4 25	$826M	$595M	$172M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	11.1x	58.8x
Q2 23	10.8x	57.9x
Q3 23	9.7x	75.0x
Q4 23	7.5x	96.3x
Q1 24	6.2x	177.7x
Q2 24	5.3x	291.0x
Q3 24	4.8x	129.4x
Q4 24	4.7x	114.9x
Q1 25	4.7x	63.8x
Q2 25	4.5x	33.2x
Q3 25	4.3x	27.9x
Q4 25	4.0x	22.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$53M	$37M
Q2 23	$35M	$17M
Q3 23	$50M	$29M
Q4 23	$105M	$82M
Q1 24	$52M	$24M
Q2 24	$54M	$26M
Q3 24	$204M	$162M
Q4 24	$210M	$193M
Q1 25	$177M	$136M
Q2 25	$78M	$31M
Q3 25	$250M	$219M
Q4 25	$249M	$192M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$16M
Q2 23	$18M
Q3 23	$22M
Q4 23	$23M
Q1 24	$29M
Q2 24	$28M
Q3 24	$42M
Q4 24	$17M
Q1 25	$41M
Q2 25	$47M
Q3 25	$31M
Q4 25	$56M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+20.0%	+19.7%
Q2 23	+10.6%	+15.1%
Q3 23	+51.0%	+97.1%
Q4 23	+124.6%	+175.1%
Q1 24	+119.3%	+171.8%
Q2 24	+115.9%	+157.3%
Q3 24	+63.1%	+50.7%
Q4 24	+6.6%	-1.5%
Q1 25	-1.4%	-16.3%
Q2 25	+18.4%	+15.4%
Q3 25	+22.9%	+9.8%
Q4 25	+25.7%	+9.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$9M	3.2%
Q2 23	$9M	2.9%
Q3 23	$23M	5.9%
Q4 23	$12M	2.0%
Q1 24	$17M	2.8%
Q2 24	$13M	2.0%
Q3 24	$12M	2.0%
Q4 24	$12M	1.8%
Q1 25	$13M	2.2%
Q2 25	$14M	1.8%
Q3 25	$12M	1.5%
Q4 25	$11M	1.4%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$21M	$122M
Q2 23	$21M	$120M
Q3 23	$29M	$156M
Q4 23	$52M	$245M
Q1 24	$57M	$249M
Q2 24	$38M	$239M
Q3 24	$35M	$241M
Q4 24	$33M	$253M
Q1 25	$33M	$243M
Q2 25	$40M	$304M
Q3 25	$38M	$314M
Q4 25	$74M	$456M

Revenue Segments

Quarter	Emerging Technology	Spine
Q1 23	$25M	$252M
Q2 23	$35M	$257M
Q3 23	$28M	$347M
Q4 23	$33M	$592M
Q1 24	$32M	$575M
Q2 24	$37M	$593M
Q3 24	$38M	$587M
Q4 24	$47M	$610M
Q1 25	$22M	$576M
Q2 25	$35M	$710M
Q3 25	$28M	$741M

Revenue by Geography

Quarter	Non Us	United States
Q1 23	$43M	$234M
Q2 23	$46M	$245M
Q3 23	$74M	$309M
Q4 23	$126M	$491M
Q1 24	$124M	$483M
Q2 24	$130M	$499M
Q3 24	$130M	$496M
Q4 24	$135M	$522M
Q1 25	$114M	$484M
Q2 25	$145M	$601M
Q3 25	$151M	$618M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$218M	$287M	$504M
Q2 23	$306M	$306M	$613M
Q3 23	$280M	$189M	$469M
Q4 23	$467M	$50M	$518M
Q1 24	$354M	$80M	$434M
Q2 24	$410M	$83M	$493M
Q3 24	$623M	$72M	$695M
Q4 24	$784M	$106M	$890M
Q1 25	$461M	$0	$461M
Q2 25	$229M	$0	$229M
Q3 25	$372M	$19M	$391M
Q4 25	$526M	$31M	$557M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	102M	-0.0%
Q2 23	102M	-0.4%
Q3 23	115M	+13.2%
Q4 23	139M	+20.6%
Q1 24	135M	-2.6%
Q2 24	137M	+1.2%
Q3 24	138M	+0.8%
Q4 24	140M	+1.2%
Q1 25	140M	+0.0%
Q2 25	136M	-2.3%
Q3 25	135M	-0.8%
Q4 25	137M	+1.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$527K	900
FY 15	$454K	1K
FY 16	$403K	1K
FY 17	$424K	2K
FY 18	$396K	2K
FY 19	$393K	2K
FY 20	$359K	2K
FY 21	$399K	2K
FY 22	$393K	3K
FY 23	$314K	5K
FY 24	$315K	8K
FY 25	$367K	8K